Next week marks the beginning of a significant clinical trial aimed at addressing the ongoing outbreak of Bundibugyo ebolavirus in Central Africa.
This initiative will evaluate the effectiveness of two drugs designed to combat the virus, which has been spreading quickly in the region.
According to officials from the World Health Organization, the trial is a crucial step in the response to this public health crisis.
Updates
Update at 16:32 UTC on 2026-06-24
STAT reported A clinical trial testing two drugs against the Bundibugyo ebolavirus, which is driving a fast-moving outbreak in Central Africa, is set to begin next week, WHO officials said.
Sources: STAT